Gaviscon and Prinivil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate) and Prinivil (lisinopril). Common drug interactions include bile duct obstruction among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Gaviscon and Prinivil. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Prinivil?

Prinivil has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 20,152 Prinivil users. Check the latest studies of Prinivil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 15, 2026

15 people who take Gaviscon and Prinivil together, and have interactions are studied.

Gaviscon and Prinivil drug interactions.

What are the common drug interactions of Gaviscon and Prinivil, by gender? *:

female:

  1. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  2. Chronic kidney disease
  3. Cystitis (inflammation of the wall of the bladder)
  4. Renal failure (kidney dysfunction)
  5. Urinary tract infection
  6. Abdominal pain upper
  7. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  8. Confusion
  9. Diarrhoea
  10. Dizziness (excl vertigo)

male:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Blood glucose increased
  5. Cardiac enzymes increased
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  9. Gouty arthritis (joint inflammation with crystal formation)
  10. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

What are the common drug interactions of Gaviscon and Prinivil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  2. Confusion
  3. Diarrhoea
  4. Dizziness (excl vertigo)
  5. Dysgeusia (disorder of the sense of taste)
  6. Eructation (release of gas from the digestive tract)
  7. Loose stools
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nausea (feeling of having an urge to vomit)
  10. Oral candidiasis (fungal infection of mouth)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Gastrointestinal pain
  4. Infection
  5. Pain
  6. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  8. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  9. Cystitis (inflammation of the wall of the bladder)
  10. Fistula (an abnormal connection or passageway between two)

What are the existing conditions these people have? *

  1. Pain: 5 people, 33.33%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 13.33%
  3. High Blood Cholesterol: 2 people, 13.33%
  4. Cardiac Disorder: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and Prinivil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gaviscon and Prinivil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prinivil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gaviscon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prinivil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate and lisinopril (the active ingredients of Gaviscon and Prinivil, respectively), and Gaviscon and Prinivil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: